financetom
Business
financetom
/
Business
/
Amneal Pharmaceuticals Insider Sold Shares Worth $775,000, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Amneal Pharmaceuticals Insider Sold Shares Worth $775,000, According to a Recent SEC Filing
Aug 16, 2024 1:47 PM

04:23 PM EDT, 08/16/2024 (MT Newswires) -- Nikita Shah, Executive Vice President, on August 14, 2024, sold 100,000 shares in Amneal Pharmaceuticals ( AMRX ) for $775,000. Following the Form 4 filing with the SEC, Shah has control over a total of 291,666 shares of the company, with 291,666 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1723128/000162828024037557/xslF345X03/wk-form4_1723839453.xml

Price: 8.10, Change: +0.06, Percent Change: +0.75

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
AstraZeneca threatens to move UK vaccine production to US, FT reports
AstraZeneca threatens to move UK vaccine production to US, FT reports
Aug 29, 2024
(Reuters) - AstraZeneca ( AZN ) has warned it could relocate its vaccine manufacturing site from the UK to the United States as talks with the new Labour government over plans to cut state aid have become deadlocked, the Financial Times reported on Thursday. British finance minister Rachel Reeves wants to reduce state provisions to the company's vaccine centre, which...
Tuya Reports Better-Than-Expected Q2 Results, Special Cash Dividend, CFO Transition
Tuya Reports Better-Than-Expected Q2 Results, Special Cash Dividend, CFO Transition
Aug 29, 2024
Tuya Inc. ( TUYA ) reported its second-quarter financial results after Monday's closing bell. Here's a look at the key figures from the quarter.  The Details: Tuya ( TUYA ) reported quarterly earnings of 4 cents per share, which beat the analyst consensus estimate of 2 cents by 100%. Quarterly revenue came in at $73.28 million, which beat the analyst...
Lifecore Biomedical Fiscal Q4 Loss Narrows, Revenue Rises; Fiscal 2025 Revenue Outlook Set
Lifecore Biomedical Fiscal Q4 Loss Narrows, Revenue Rises; Fiscal 2025 Revenue Outlook Set
Aug 29, 2024
05:52 PM EDT, 08/26/2024 (MT Newswires) -- Lifecore Biomedical ( LFCR ) reported a fiscal Q4 net loss from continuing operations late Monday of $7.09 million, compared with the loss of $37 million a year earlier. Revenue in the quarter ended May 26 rose to $37.9 million from $31.1 million a year earlier. Two analysts surveyed by Capital IQ expected...
Mgp Ingredients Insider Sold Shares Worth $1,096,141, According to a Recent SEC Filing
Mgp Ingredients Insider Sold Shares Worth $1,096,141, According to a Recent SEC Filing
Aug 29, 2024
05:55 PM EDT, 08/26/2024 (MT Newswires) -- Karen Seaberg, 10% Owner, Director, on August 23, 2024, sold 12,092 shares in Mgp Ingredients ( MGPI ) for $1,096,141. Following the Form 4 filing with the SEC, Seaberg has control over a total of 136,078 shares of the company, with 136,078 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/835011/000181734924000007/xslF345X05/primary_doc.xml ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved